U.S. Markets closed
  • S&P Futures

    4,064.50
    -11.00 (-0.27%)
     
  • Dow Futures

    33,998.00
    -25.00 (-0.07%)
     
  • Nasdaq Futures

    12,045.00
    -61.75 (-0.51%)
     
  • Russell 2000 Futures

    1,906.30
    -4.20 (-0.22%)
     
  • Crude Oil

    81.33
    +0.32 (+0.40%)
     
  • Gold

    1,925.90
    -4.10 (-0.21%)
     
  • Silver

    23.93
    -0.09 (-0.35%)
     
  • EUR/USD

    1.0883
    -0.0009 (-0.0871%)
     
  • 10-Yr Bond

    3.4930
    +0.0310 (+0.90%)
     
  • Vix

    18.73
    -0.35 (-1.83%)
     
  • GBP/USD

    1.2396
    -0.0011 (-0.0905%)
     
  • USD/JPY

    129.7000
    -0.4530 (-0.3481%)
     
  • BTC-USD

    22,818.05
    -394.07 (-1.70%)
     
  • CMC Crypto 200

    517.08
    -10.11 (-1.92%)
     
  • FTSE 100

    7,761.11
    +16.24 (+0.21%)
     
  • Nikkei 225

    27,381.18
    +18.43 (+0.07%)
     

Anavex Catapults On Alzheimer's Results — What The CEO Says Critics Got Wrong

Anavex Catapults On Alzheimer's Results — What The CEO Says Critics Got Wrong

Anavex Life Sciences said its experimental Alzheimer's treatment met the goals of a midstage study, leading AVXL stock to rocket early Friday.